Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRIM6-TRIM34 is a chimeric protein from a readthrough transcript between TRIM6 and TRIM34 genes, members of the tripartite motif (TRIM) protein family. TRIM proteins possess a conserved domain architecture with a RING finger domain, B-box types 1 and 2, and a coiled-coil region. These domains mediate protein-protein interactions and facilitate E3 ubiquitin ligase activity, which marks substrates for protein degradation or regulatory modification. TRIM6-TRIM34 localizes to chromosome 11p15 and may play roles in innate immunity, cellular stress response, and regulation of protein homeostasis. Functional studies on related TRIM chimeras indicate activity in retroviral restriction and immune modulation, but specific data for TRIM6-TRIM34 remain limited[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 6 and tripartite motif-containing protein 34 (TRIM6-TRIM34).